Treatment of Testicular Relapse of B-cell Acute Lymphoblastic Leukemia With CD19-specific Chimeric Antigen Receptor T Cells
Clinical Lymphoma Myeloma & Leukemia2019Vol. 20(6), pp. 366–370
Citations Over TimeTop 15% of 2019 papers
Xiaojuan Chen, Ying Wang, Min Ruan, Jun Li, Mengjun Zhong, Zhanqi Li, Fang Liu, Shuchun Wang, Yumei Chen, Lipeng Liu, Jun J. Yang, Xiaofan Zhu, Jianxiang Wang, Ching‐Hon Pui
Related Papers
- → Use of CAR-Transduced Natural Killer Cells in CD19-Positive Lymphoid Tumors(2020)2,047 cited
- → 4-1BB costimulation ameliorates T cell exhaustion induced by tonic signaling of chimeric antigen receptors(2015)1,752 cited
- → B cell targeting in CAR T cell therapy: Side effect or driver of CAR T cell function?(2022)20 cited
- → Distribution Measurements of Chimeric Antigen Receptor-Modified T Cells Against CD19(2020)
- → Anti-cd19-car-transduced-t-cells/chimeric-antigen-receptor-t-cell-therapeutics-shanghai-unicar-therapy-bio-medicine-technology(2019)